These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31583278)

  • 1. Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy.
    Ng SP; Pollard C; Kamal M; Ayoub Z; Garden AS; Bahig H; Gunn GB; Frank SJ; Skinner HD; Phan J; Berends J; Morrison WH; Johnson JM; Ferrarotto R; Sturgis EM; Mohamed ASR; Lai SY; Fuller CD; Rosenthal DI
    NPJ Precis Oncol; 2019; 3():22. PubMed ID: 31583278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
    Jung YS; Lim J; Jung KW; Ryu J; Won YJ
    PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
    Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
    Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature.
    Atienza JA; Dasanu CA
    Curr Med Res Opin; 2012 Dec; 28(12):1899-909. PubMed ID: 23121148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery.
    Vawda N; Banerjee RN; Debenham BJ
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1125-1131. PubMed ID: 30513378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second primary malignancies in patients with cancer of the head and neck.
    Vaamonde P; Martín C; del Río M; LaBella T
    Otolaryngol Head Neck Surg; 2003 Jul; 129(1):65-70. PubMed ID: 12869919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?
    Adeel M; Siddiqi MI
    J Korean Assoc Oral Maxillofac Surg; 2018 Oct; 44(5):220-224. PubMed ID: 30402413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct features of second primary malignancies in head and neck cancer patients in Japan.
    Shiga K; Tateda M; Katagiri K; Nakanome A; Ogawa T; Asada Y; Kato K; Kobayashi T
    Tohoku J Exp Med; 2011 Sep; 225(1):5-12. PubMed ID: 21817851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
    Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
    Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second primary malignancies in laryngeal carcinoma patients treated with definitive radiotherapy.
    Ozdemir Y; Topkan E
    Indian J Cancer; 2019; 56(1):29-34. PubMed ID: 30950440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Primary Malignancies in Head and Neck Cancer: A University Hospital Experience Over a Five-Year Period.
    Batista MV; Ulrich J; Costa L; Ribeiro LA
    Cureus; 2021 Aug; 13(8):e17349. PubMed ID: 34567890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study.
    Hoff CM; Grau C; Overgaard J
    Radiother Oncol; 2012 Apr; 103(1):38-44. PubMed ID: 22385797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of smoking history on the perception of radiation-induced dysgeusia/hypogeusia in patients with head and neck cancer.
    Park D; Jain S; Quay-De La Vallee Z; Huber K; O'Leary M; Farag AM
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):2993-3001. PubMed ID: 33128589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Clinical Report on Comparative Treatment and Survival Outcomes in Second Cancers after Primary Head and Neck Cancer: A Population-Based Study.
    Wang X; Mauer EA; Christos P; Manzerova J; Wernicke AG; Parashar B
    Cureus; 2017 May; 9(5):e1284. PubMed ID: 28680772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.